Stand D35 / 3

2025 Edition

CARLA Biotherapeutics

France

Carla Biotherapeutics is a preclinical stage company advancing lead programs targeting hematological malignancies and solid tumors. We are advancing a proprietary CAR-T platform plug-and-play technology to rapidly and efficiently develop precision medicines for severe and aggressive diseases.

Scroll to Top
  • No products in the cart.